Doença arterial coronariana aguda (2016)
- Authors:
- Autor USP: NICOLAU, JOSÉ CARLOS - FM
- Unidade: FM
- Subjects: DOENÇAS CARDIOVASCULARES; INFARTO DO MIOCÁRDIO
- Language: Português
- Imprenta:
- Publisher: Manole
- Publisher place: Barueri, SP
- Date published: 2016
- ISBN: 9788520440902
- Source:
-
ABNT
FERNANDES, Felipe Lourenço e GANEM, Fernando e NICOLAU, José Carlos. Doença arterial coronariana aguda. Perguntas e respostas comentadas em cardiologia. Tradução . Barueri, SP: Manole, 2016. . . Acesso em: 23 jan. 2026. -
APA
Fernandes, F. L., Ganem, F., & Nicolau, J. C. (2016). Doença arterial coronariana aguda. In Perguntas e respostas comentadas em cardiologia. Barueri, SP: Manole. -
NLM
Fernandes FL, Ganem F, Nicolau JC. Doença arterial coronariana aguda. In: Perguntas e respostas comentadas em cardiologia. Barueri, SP: Manole; 2016. [citado 2026 jan. 23 ] -
Vancouver
Fernandes FL, Ganem F, Nicolau JC. Doença arterial coronariana aguda. In: Perguntas e respostas comentadas em cardiologia. Barueri, SP: Manole; 2016. [citado 2026 jan. 23 ] - P2Y12 inhibitor switching in response to routine notification of CYP2C19 clopidogrel metabolizer status following acute coronary syndromes
- Impact of the Extent of Coronary and Myocardial Disease on the Treatment Effect of Surgical Revascularization in Patients With Ischemic Left Ventricular Dysfunction
- Rationale and design of the long-Term rIsk, clinical manaGement, and healthcare Resource utilization of stable coronary artery dISease in post-myocardial infarction patients (TIGRIS) study
- Ticagrelor versus clopidogrel in patients with STEMI treated with fibrinolysis TREAT trial
- Ticagrelor for the prevention of ischemic events in patients with prior myocardial infarction and peripheral artery disease
- Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial
- Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease
- Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countries
- Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial
- Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
